. Author manuscript; available in PMC: 2019 Sep 26.

Published in final edited form as: Paediatr Perinat Epidemiol. 2018 Jul 4;32(4):337–345. doi: 10.1111/ppe.12485

Table 4.

Immune markers in newborns and use of developmental services at 30 and 36 months (n=2092).

	Any service use reported by parents at 30 and 36 months (yes=370)

Exposure	OR (95%CI)

	Unadjusted	Adjusted
PDGF-AA
	0.92 (0.82, 1.03)	0.97 (0.87, 1.09)
PAI-1
	0.89 (0.80, 0.99)	0.92 (0.83, 1.03)
SDF-1
	0.98 (0.88, 1.10)	1.02 (0.91, 1.15)
MIP-1β
	0.87 (0.79, 0.96)	0.95 (0.86, 1.06)

Platelet-derived growth factor-AA (PDGF-AA), Plasminogen activator inhibitor-1 (PAI-1), Stromal cell derived factor 1 (SDF-1), Macrophage inflammatory protein 1 beta (MIP-1β)

Odds ratios refer to the effect estimates per standard deviation change in levels of immune marker (in logarithmic scale or square-root).

Models adjusted for a child’s sex, maternal age, maternal educational levels, maternal race, maternal history of smoking in pregnancy and drinking alcohol, maternal pre-pregnancy body mass index, having private insurance, parity, history of infertility treatment, plurality, mode of delivery, gestational age, and birthweight.